The advances in cardiothoracic surgery have been outstanding over the last 100 years from the 1st successful pneumonectomy in 1933 to the 1st cardiopulmonary bypass in the 1953.  Technology is advancing a very rapid rate in both cardiac and thoracic surgery.  Cardiac surgery embraces minimally invasive surgeries, percutaneous treatment of valvular disorders, and percutaneous aortic interventions.  In the thoracic realm advances in surgical intervention and diagnostics is a constantly involving door.  The impact on surgical and medical treatment includes better diagnostic modalities, less invasive procedures, safer procedures, faster recovery improved medical therapies.  Given the broad scope of advancement the in medical therapy and surgical interventions of cardiac in thoracic surgery today we will be discussing advances in minimally invasive thoracic surgery.

The planners of this activity disclosed no financial relationships with ineligible companies whose primarybusiness is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients,with the exception of Winston Ortiz, M.D. Dr. Ortiz disclosed that he is member of the speaker’s bureau for Allergan and TEVA.
Dr. Juan Gallegos, speaker for this educational event, has no relevant financial relationships with ineligible
companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.